Cargando…
Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer
Oncogenic, activating mutations in KRAS initiate pancreatic cancer. There are, however, two other Ras family members, Nras and Hras, which can be activated in the presence of oncogenic Kras. The role of these wild-type Ras proteins in cancer remains unclear, as their disruption has been shown to enh...
Autores principales: | Weyandt, Jamie D., Lampson, Benjamin L., Tang, Sherry, Mastrodomenico, Matthew, Cardona, Diana M., Counter, Christopher M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599940/ https://www.ncbi.nlm.nih.gov/pubmed/26452271 http://dx.doi.org/10.1371/journal.pone.0140253 |
Ejemplares similares
-
Reduced HRAS(G12V)-Driven Tumorigenesis of Cell Lines Expressing KRAS(C118S)
por: Huang, Lu, et al.
Publicado: (2015) -
Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice
por: Weyandt, Jamie D., et al.
Publicado: (2016) -
Decreased tumorigenesis in mice with a Kras point mutation at C118
por: Huang, Lu, et al.
Publicado: (2014) -
The Earliest Stages of Delinquency
Publicado: (1952) -
LEF1/Id3/HRAS axis promotes the tumorigenesis and progression of esophageal squamous cell carcinoma
por: Wang, Xinyu, et al.
Publicado: (2020)